School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Mary Sweeney MD

  • Department of Medicine
    Associate Professor
  • (404) 778-3280
  • msweene@emory.edu
Head shot of Mary Sweeney

Overview

Mary Ellen Sweeney, MD, is interested in the diagnosis and treatment of lipid disorders, both familial and those related to obesity, insulin resistance, metabolic disorders and diet.

Her research interests include assessment of the metabolic effects of diet and various types of exercise on body composition and glucose and lipid metabolism in patients with cardiovascular disease.

She is currently involved in research concerning the intensity of blood pressure and diabetes control and how it relates to cardiovascular disease and quality of life.

Interests

Assessment of the metabolic effects of diet and various types of exercise on body composition and glucose and lipid metabolism in patients with cardiovascular disease

Achievements

American Heart Association 2004 Advocate of the Year Award
Appointed to the Georgia House of Representatives Task Force for the Study of Obesity in Georgia; 2004-2005

Associations

National Lipid Association 2003-present
Southeast Lipid Association 1999-present
North American Association for the Study of Obesity, 1987-93.
The Endocrine Society - member, 1995-Present
American Association of Clinical Endocrinologists (AACE)

Academic Appointment

  • Master Clinician, Emory University School of Medicine
  • Associate Professor of Medicine, Department of Medicine, Emory University School of Medicine

Education

Degrees

  • DO from Medical College of Ohio
  • BS from University of Toledo

Research

Focus

  • I am interested in the metabolic effects of diet and various types of exercise on body composition and glucose and lipid metabolism in patients with cardiovascular disease. I am particularly involved in studies in patients with insulin resistance or metabolic syndrome and the effects of early intervention strategies.

Publications

  • GREENSPACE IN RELATION TO SLEEP HEALTH AMONG A RACIALLY AND ETHNICALLY DIVERSE COHORT OF US WOMEN
    Volume: 46 Page(s): A106 - U341
    05/01/2023 Authors: Gaston S; Sweeney M; Martinez-Miller E; Jones R; James P; Jackson WB; Sandler D; Jackson C
  • Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Am J Kidney Dis Volume: 79 Page(s): 677 - 687.e1
    05/01/2022 Authors: Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J
  • Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes.
    Hypertension Volume: 77 Page(s): 1391 - 1398
    04/01/2021 Authors: Wright CB; Auchus AP; Lerner A; Ambrosius WT; Ay H; Bates JT; Chen J; Meschia JF; Pancholi S; Papademetriou V
  • Outcomes in adults with systolic blood pressure between 130 and 139mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
    J Hypertens Volume: 38 Page(s): 1567 - 1577
    08/01/2020 Authors: Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J
  • Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized Trial.
    Hypertension Volume: 75 Page(s): 331 - 338
    02/01/2020 Authors: Roumie CL; Hung AM; Russell GB; Basile J; Kreider KE; Nord J; Ramsey TM; Rastogi A; Sweeney ME; Tamariz L
  • Cardiovascular Outcomes in Adults With Systolic Blood Pressure Between 130 and 139 mmHg at Screening in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Volume: 138
    11/06/2018 Authors: Contreras G; Lu L; Tamariz L; Rocco M; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J
  • Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial.
    Diabetes Care Volume: 40 Page(s): 1401 - 1408
    08/09/2017 Authors: Bress AP; King JB; Kreider KE; Beddhu S; Simmons DL; Cheung AK; Zhang Y; Doumas M; Nord J; Sweeney ME
  • Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    JAMA Cardiol Volume: 2 Page(s): 370 - 380
    04/01/2017 Authors: Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D
  • VAMONOS (Veterans Affairs' Metabolism, Obstructed and Non-Obstructed Sleep) Study: Effects of CPAP Therapy on Glucose Metabolism in Patients with Obstructive Sleep Apnea.
    J Clin Sleep Med Volume: 13 Page(s): 455 - 466
    03/15/2017 Authors: Ioachimescu OC; Anthony J; Constantin T; Ciavatta M-M; McCarver K; Sweeney ME
  • Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
    JAMA Intern Med Volume: 177 Page(s): 67 - 76
    01/01/2017 Authors: Puttnam R; Davis BR; Pressel SL; Whelton PK; Cushman WC; Louis GT; Margolis KL; Oparil S; Williamson J; Ghosh A
  • Alternative Metabolic Parameters of Cardiovascular Risk in OSA Patients
    Volume: 150 Page(s): 1262A - 1262A
    10/01/2016 Authors: Hsieh S; Havranek R; Ciavatta M-M; Constantin T; Thomas M; Miller J; McCarver K; Anthony J; Sweeney ME; Ioachimescu O
  • The Effects of CPAP Therapy on Cardiometabolic Parameters in a Cohort of 925 Veterans Seen in Sleep Medicine Clinics
    CHEST Volume: 148
    10/01/2015 Authors: Anthony J; Ciavatta M-M; Constantin T; McCarver K; Sweeney M-E; Ioachimescu O
  • Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.
    Am J Hypertens Volume: 28 Page(s): 995 - 1009
    08/01/2015 Authors: Espeland MA; Probstfield J; Hire D; Redmon JB; Evans GW; Coday M; Lewis CE; Johnson KC; Wilmoth S; Bahnson J
  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med Volume: 373 Page(s): 232 - 242
    07/16/2015 Authors: Green JB; Bethel MA; Armstrong PW; Buse JB; Engel SS; Garg J; Josse R; Kaufman KD; Koglin J; Korn S
  • Effect of ABT-335 (fenofibric acid) on meal-induced oxidative stress in patients with metabolic syndrome.
    Atherosclerosis Volume: 231 Page(s): 268 - 273
    12/01/2013 Authors: Le N-A; Farkas-Epperson M; Sweeney ME; Wilson PWF; Virgil Brown W
  • Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.
    Am Heart J Volume: 164 Page(s): 925 - 31.e2
    12/01/2012 Authors: Drawz PE; Baraniuk S; Davis BR; Brown CD; Colon PJ; Cujyet AB; Dart RA; Graumlich JF; Henriquez MA; Moloo J
  • 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    J Am Coll Cardiol Volume: 60 Page(s): 1297 - 1313
    10/02/2012 Authors: Tracy CM; Epstein AE; Darbar D; Dimarco JP; Dunbar SB; Estes NAM; Ferguson TB; Hammill SC; Karasik PE; Link MS
  • Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.
    Circ Cardiovasc Qual Outcomes Volume: 5 Page(s): 153 - 162
    03/01/2012 Authors: Barzilay JI; Davis BR; Pressel SL; Cutler JA; Einhorn PT; Black HR; Cushman WC; Ford CE; Margolis KL; Moloo J
  • Effect of Fenofibrate Therapy on Cardiovascular Disease in Men versus Women with Type 2 Diabetes in the ACCORD-Lipid Trial
    CIRCULATION Volume: 122
    11/23/2010 Authors: Lovato LC; Elam MB; Byington RP; Sweeney ME; Sperl-Hillen JM; Fleg J; Weiss D; Lorber DL; Ginsberg HN
  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
    BMJ Volume: 340 Page(s): b4909
    01/08/2010 Authors: Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B
  • Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.
    Clin Trials Volume: 6 Page(s): 416 - 429
    10/01/2009 Authors: Mount DL; Feeney P; Fabricatore AN; Coday M; Bahnson J; Byington R; Phelan S; Wilmoth S; Knowler WC; Hramiak I
  • Effects of intensive glucose lowering in type 2 diabetes.
    N Engl J Med Volume: 358 Page(s): 2545 - 2559
    06/12/2008 Authors: Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC; Miller ME; Byington RP; Goff DC; Bigger JT; Buse JB; Cushman WC; Genuth S; Ismail-Beigi F
  • Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Expert Opin Drug Metab Toxicol Volume: 3 Page(s): 441 - 450
    06/01/2007 Authors: Sweeney ME; Johnson RR
  • Lifestyle physical activity in hypertensive rural elders: Association with self-efficacy related constructs
    Volume: 115 Page(s): E250 - E250
    02/27/2007 Authors: Gee RM; Dunbar SB; Dilorio CK; Clark PC; Kimble LP; Sweeney ME
  • CETP and LCAT contribute to formation of small dense LDL in vitro
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Volume: 22 Page(s): A73 - A73
    05/01/2002 Authors: Huey PU; Li XZ; Patel H; Sweeney ME; Davis W; Brown WV; Le NA
  • Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Diabetes Care Volume: 24 Page(s): 654 - 658
    04/01/2001 Authors: Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group
  • The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.
    Am Heart J Volume: 140 Page(s): 541 - 551
    10/01/2000 Authors: Lamas GA; Lee K; Sweeney M; Leon A; Yee R; Ellenbogen K; Greer S; Wilber D; Silverman R; Marinchak R
  • Debate: The potential role of estrogen in the prevention of heart disease in women after menopause.
    Curr Control Trials Cardiovasc Med Volume: 1 Page(s): 139 - 142
    01/01/2000 Authors: Johnson RR; Sweeney ME
  • Effect of weight loss on blood pressure in obese coronary artery disease subjects: Is it diet or exercise?
    CIRCULATION Volume: 100 Page(s): 737 - 737
    11/02/1999 Authors: Fletcher BJ; Dunbar SB; Sweeney ME; Fletcher GF
  • INCIDENCE OF UNDIAGNOSED HYPERINSULINEMIA AND EFFECTS OF TREATMENT IN OBESE PATIENTS WITH CORONARY-ARTERY DISEASE
    Volume: 44 Page(s): A205 - A205
    05/01/1995 Authors: SWEENEY ME; ALMON L; LAWE C; HALL WD; FLETCHER GF
  • CHANGES IN INTRAABDOMINAL AND SUBCUTANEOUS ADIPOSE-TISSUE WITH DIFFERENT LEVELS OF CALORIC RESTRICTION AND EXERCISE
    CIRCULATION Volume: 90 Page(s): 101 - 101
    10/01/1994 Authors: SWEENEY ME; NELSON RC; ALMON ML; LONG RC; HALL WD; FLETCHER GF
  • EFFECTS OF SEVERE AND MODERATE CALORIC RESTRICTION AND EXERCISE ON BLOOD-PRESSURE IN OBESE CORONARY-ARTERY DISEASE SUBJECTS
    CIRCULATION Volume: 90 Page(s): 590 - 590
    10/01/1994 Authors: DUNBAR SB; SWEENEY ME; FLETCHER BJ; ALMON ML; COTSONIS G; HALL WD; FLETCHER GF
  • INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 RESPONSES IN OBESE PATIENTS BEFORE AND AFTER WEIGHT-LOSS
    CLINICAL RESEARCH Volume: 42 Page(s): A173 - A173
    04/01/1994 Authors: SWEENEY ME; ROBERTSON DG; PHILLIPS LS
  • RELATIONSHIPS AMONG BLOOD-PRESSURE, BODY-WEIGHT AND COMPOSITION IN OBESE CORONARY PATIENTS
    CIRCULATION Volume: 88 Page(s): 518 - 518
    10/01/1993 Authors: DUNBAR SB; SWEENEY ME; FLETCHER BJ; FLETCHER GF; HALL WD; ALMON L; LAW C
  • EFFECT OF WEIGHT-LOSS ON LDL PARTICLE-SIZE AND POSTPRANDIAL LIPEMIA IN OBESE SUBJECTS WITH CAD
    CIRCULATION Volume: 88 Page(s): 364 - 364
    10/01/1993 Authors: SWEENEY ME; LE NA; LI XZ; INNISWHITEHOUSE W; DAVIS L; UMEAKUNNE K; HALL WD; FLETCHER G; BROWN WV
  • Severe vs moderate energy restriction with and without exercise in the treatment of obesity: efficiency of weight loss.
    Am J Clin Nutr Volume: 57 Page(s): 127 - 134
    02/01/1993 Authors: Sweeney ME; Hill JO; Heller PA; Baney R; DiGirolamo M
  • EFFECT OF EXERCISE TRAINING ON DIETARY ADHERENCE AND BLOOD-LIPIDS IN PHYSICALLY DISABLED SUBJECTS WITH CORONARY-ARTERY DISEASE
    CIRCULATION Volume: 86 Page(s): 241 - 241
    10/01/1992 Authors: FLETCHER BJ; ALMON L; JENSEN BE; SWEENEY ME; FLETCHER GF
  • Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia.
    Am J Med Volume: 90 Page(s): 469 - 473
    04/01/1991 Authors: Sweeney ME; Fletcher BJ; Rice CR; Berra KA; Rudd CM; Fletcher GF; Superko RS
  • Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade.
    Am Heart J Volume: 121 Page(s): 105 - 110
    01/01/1991 Authors: Fletcher GF; Sweeney ME; Fletcher BJ
  • Effects of exercise testing, training and beta blockade on serum potassium in normal subjects.
    Am J Cardiol Volume: 65 Page(s): 1242 - 1245
    05/15/1990 Authors: Fletcher GF; Fletcher BJ; Sweeney ME
  • Exercise testing and training with beta-adrenergic blockade: role of the drug washout period in "unmasking" a training effect.
    Am Heart J Volume: 118 Page(s): 941 - 946
    11/01/1989 Authors: Sweeney ME; Fletcher BJ; Fletcher GF
  • EFFECT OF DEGREE OF FOOD RESTRICTION AND EXERCISE ON LEFT-VENTRICULAR MASS
    CIRCULATION Volume: 76 Page(s): 457 - 457
    10/01/1987 Authors: SWEENEY ME; HELLER PA; HILL JO; BANEY R; DIGIROLAMO M
  • SELECTIVE VS NONSELECTIVE BETA-BLOCKADE THERAPY IN EXERCISE TRAINING
    CIRCULATION Volume: 76 Page(s): 363 - 363
    10/01/1987 Authors: SWEENEY ME; FLETCHER GF; THIEL JE; FLETCHER BJ
  • BODY-COMPOSITION DURING WEIGHT-REDUCTION - EFFECTS OF DEGREE OF FOOD RESTRICTION AND TYPE OF EXERCISE
    INTERNATIONAL JOURNAL OF OBESITY Volume: 11 Page(s): A462 - A462
    01/01/1987 Authors: HILL JO; HELLER PA; SWEENEY ME; BANEY R; DIGIROLAMO M
  • CARDIOVASCULAR AND METABOLIC EFFECTS OF SHORT-TERM SEMISTARVATION
    Volume: 34 Page(s): A393 - A393
    04/01/1986 Authors: SWEENEY ME; HEYMSFIELD SB; HELLER T; HILL J; CASPER K
  • CARDIOVASCULAR AND METABOLIC EFFECTS OF SHORT-TERM SEMISTARVATION
    Volume: 34 Page(s): A177 - A177
    01/01/1986 Authors: SWEENEY ME; HEYMSFIELD SB; HELLER T; HILL J; CASPER K
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information